Literature DB >> 9036766

Prevalence of echocardiographic findings in 554 men and in 1,243 women aged > 60 years in a long-term health care facility.

W S Aronow1, C Ahn, I Kronzon.   

Abstract

The prevalence of mitral regurgitation, valvular aortic stenosis, aortic regurgitation, hypertrophic cardiomyopathy, idiopathic dilated cardiomyopathy, and of left ventricular hypertrophy was not significantly different in older men and women. Older women had a significantly higher prevalence of rheumatic mitral stenosis, mitral annular calcium, and left atrial enlargement than older men, and older men had a significantly higher prevalence of abnormal left ventricular ejection fraction than older women.

Entities:  

Mesh:

Year:  1997        PMID: 9036766     DOI: 10.1016/s0002-9149(96)00769-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study.

Authors:  Joanna L d'Arcy; Sean Coffey; Margaret A Loudon; Andrew Kennedy; Jonathan Pearson-Stuttard; Jacqueline Birks; Eleni Frangou; Andrew J Farmer; David Mant; Jo Wilson; Saul G Myerson; Bernard D Prendergast
Journal:  Eur Heart J       Date:  2016-06-26       Impact factor: 29.983

2.  Impact of valvular heart disease on activities of daily living of nonagenarians: the Leiden 85-plus study a population based study.

Authors:  Thomas van Bemmel; Victoria Delgado; Jeroen J Bax; Jacobijn Gussekloo; Gerard J Blauw; Rudi G Westendorp; Eduard R Holman
Journal:  BMC Geriatr       Date:  2010-04-01       Impact factor: 3.921

3.  The OxVALVE population cohort study (OxVALVE-PCS)-population screening for undiagnosed valvular heart disease in the elderly: study design and objectives.

Authors:  Sean Coffey; Joanna L d'Arcy; Margaret A Loudon; David Mant; Andrew J Farmer; Bernard D Prendergast
Journal:  Open Heart       Date:  2014-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.